Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-011450-18Phase 4Completed
Phase 4, open-label trial of omeprazole in influenza (2 arms), sponsored by CSL Limited. Primary endpoints: Immunogenicity and Safety. Started Apr 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-011450-18.